Abstract

Rheumatoid arthritis (RA) is a widespread inflammatory disease whose clinical manifestations are joint swelling, pain, and disability, affecting approximately 1% of individuals worldwide. Conventional anti-RA drugs currently used in clinic have severe side effects. The present study is aimed at investigating the antiarthritic effects of total saponins from Nigella glandulifera seeds (TSNGS) in rats with adjuvant-induced rheumatoid arthritis (AIA). Arthritis score, paw swelling, and body weight were monitored throughout the period of TSNGS treatment. The histopathological features and levels of cytokines, including IFN-γ, TNF-α, IL-1β, IL-4, IL-6, IL-10, and IL-17A, and OPG/RANKL signaling, were measured to determine the amelioration by TSNGS and its potential mechanisms on the inflammatory response and bone erosion. The differentiation of regulatory T cells (Tregs) in serum was assessed by flow cytometry. The results demonstrate that TSNGS at 10 mg/kg, 50 mg/kg, and 250 mg/kg inhibited AIA-induced clinical score, paw swelling, and histological changes. TSNGS reduced the immune-inflammatory reaction by restoring the secretion and expression of inflammatory cytokines and elevating the proportion of CD4+ CD25+ Tregs, accompanied by an increase in transcription factor Foxp3 levels. TSNGS also displayed bone protection by upregulation of the OPG/RANKL pathway. Collectively, TSNGS inhibited arthritis in AIA rats and so represents a potential novel treatment for RA.

Highlights

  • Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease of unknown etiology, characterized by synovial inflammation and hyperplasia, the formation of pannus, and cartilage destruction that result in irreversible joint damage and severe disability [1]

  • We have investigated the therapeutic effects of total saponins from Nigella glandulifera seeds (TSNGS) in an adjuvant-induced rheumatoid arthritis (AIA) rat model and explored the potential mechanism by which immuno-inflammatory function is recovered and bone erosion diminished

  • Equivalent to that in rats in which Tripterygium glycosides (TG) had been administered. These results indicate that TSNGS might reduce bone erosion by restoring the abnormal OPG/RANKL axis against RA injury

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease of unknown etiology, characterized by synovial inflammation and hyperplasia, the formation of pannus, and cartilage destruction that result in irreversible joint damage and severe disability [1]. The focus of treatment given to RA patients is currently immune suppression plus nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) to relieve their immuno-inflammatory response and the pain symptoms of RA, including Tripterygium wilfordii polyglycosides, methotrexate, and glucocorticoids. Long-term use leads to serious side effects on the kidney, bone, stomach, and other tissues and organs. The development of a drug that cures RA is urgently required for clinical use.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call